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Hemotrophic mycoplasmas infect a variety of mam-
mals. Although infection in humans is rarely reported, an 
association with an immunocompromised state has been 
suggested. We report a case of a Mycoplasma haemofelis–
like infection in an HIV-positive patient co-infected with Bar-
tonella henselae.
H
emoplasmas are a group of bacteria that infect animals. 
They are small epicellular parasites that adhere to the 
host’s erythrocytes. Diseases caused by these bacteria range 
from acute hemolytic anemia to asymptomatic infection. It 
is generally thought that most Mycoplasma spp. are host 
speciﬁ  c. However, there are occasional reports of infection 
in an animal species not perceived as primary hosts. These 
infections may have a pathologic effect, particularly when 
predisposing conditions, such as immunodeﬁ  ciency,  are 
present (1). We report a case of Mycoplasma haemofelis–
like infection in an HIV-positive patient with disseminated 
Bartonella henselae infection.
The Study
A 34-year-old HIV-positive man was hospitalized in 
Brazil in September 2006 with a 30-day history of night 
sweats; loss of appetite; productive cough; muscle pain; 
and cervical, axillary, and inguinal lymphadenomegaly. 
Results of pulmonary, cardiovascular, and abdominal ex-
aminations were normal. Abnormal lymph nodes were 2 
cm in diameter, ﬁ  rm, and not tender. The patient owned 5 
cats and showed signs of multiple cat scratches and bites 
on his hands and arms. He had received an HIV-positive 
diagnosis 5 years earlier.
At admission, his CD4 cell count was 286 cells/mm3 
(reference range 500–1,500 cells/mm3), and viral load was 
38,100 copies/mL. Additional laboratory ﬁ  ndings included 
anemia, hematocrit 29% (reference range 38%–50%); leu-
kopenia, 3,300 leukocytes/μL (4,300–10,000 leukocytes/
μL); thrombocytopenia, 108,000 platelets/μL (150,000–
450,000 platelets/μL); aspartate aminotransferase 66 U/L 
(15–40 U/L), alanine aminotransferase 79 U/L (10–40 
U/L), and lactate dehydrogenase 657 U/L (240–480 U/L). 
Blood cultures yielded no bacterial growth; sputum cultures 
were negative for acid-fast bacilli, bacteria, and fungi. Test 
results were negative for hepatitis B and C, human T lym-
photropic virus type 1, syphilis, chlamydia, and cryptococ-
cus infections. Bone marrow and lymph node biopsy and 
culture results were negative for mycobacterial or fungal 
infections.
Abdominal computed tomography showed hepato-
megaly, splenomegaly, and hypoechoic lesions on the 
spleen. Transesophageal echocardiography showed no le-
sions compatible with infective endocarditis. An inguinal 
node biopsy showed granuloma with necrosis suggesting 
cat-scratch disease, and no signs of acid-fast bacilli or 
fungi. Many bacilli suggestive of Bartonella spp. were ob-
served by Warthin-Starry staining, and antibodies against 
B. henselae (titer 256) were detected in serum. Treatment 
with doxycycline was initiated and symptoms subsequently 
subsided. The patient was discharged and instructed to con-
tinue antiretroviral therapy and oral doxycycline.
In June 2007, the patient was hospitalized with fever, 
malaise, weight loss, and lymphadenomegaly. Echocar-
diography showed mitral vegetations. Multiple hepatic 
hypoechoic lesions were found by abdominal computed 
tomography. Lymph node biopsy specimens showed tiny 
bacilli by Warthin-Starry staining. The patient had prema-
turely discontinued antiretroviral and antimicrobial drug 
treatment, which may have predisposed him to endocarditis 
and hepatic peliosis. He was treated with doxycycline and 
gentamicin for Bartonella spp. infection. His symptoms 
disappeared and an echocardiogram 17 days later showed 
resolution of mitral vegetations. He was discharged and 
instructed to continue antiretroviral therapy and oral doxy-
cycline for Bartonella spp. infection. Ten months after 
discharge, the patient returned for a follow-up visit while 
taking recommended therapy. He had no clinical signs and 
his laboratory ﬁ  ndings were improved.
During the patient’s ﬁ  rst hospitalization in 2006, blood 
was collected into tubes containing EDTA and 2 aliquots of 
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DNA were extracted (DNeasy Blood and Tissue Kit; QIA-
GEN, Valencia, CA, USA) at the Hospital de Clínicas de 
Porto Alegre. DNA was tested by PCR for Bartonella spp. 
infection (2) and by additional PCR protocols for feline he-
moplasmas, including Mycoplasma haemofelis (3), “Can-
didatus M. haemominutum” (4), and “Candidatus M. turi-
censis” (A.P. Santos, unpub. data). These bacteria infect 
cats and possible infection of this patient was investigated. 
Positive controls for M. haemofelis included DNA extract-
ed from naturally (GenBank accession no. EU930823) and 
experimentally infected cats (3). Three positive controls 
for B. henselae (type 1, type 2, and Houston strain) were 
used. Negative controls included ultrapure water and DNA 
extracted from blood of a healthy person and a noninfected 
cat. All negative controls were negative by PCR.
Amplicons of the expected size were obtained in Barto-
nella spp. and M. haemofelis PCRs. The 393-bp PCR prod-
uct for M. haemofelis (Figure) was puriﬁ  ed (Zymoclean 
Gel DNA Recovery Kit; Zymo Research, Orange, CA, 
USA), cloned (pGEM-T EasyVector; (Promega, Madison, 
WI, USA), and sequenced (Purdue Genomics Core Facil-
ity, West Lafayette, IN, USA). The fragment was 99% ho-
mologous with M. haemofelis 16S rDNA gene sequences in 
the GenBank database. To assess the sequence of the 16S 
rRNA gene, we designed species-speciﬁ  c primers based on 
the M. haemofelis sequence (forward primer 5′-ATG CAA 
GTC GAA CGG ATC TT-3′; reverse primer 5′-TCC AAT 
CAG AAT GTT CAC TC-3′). PCR product ampliﬁ  ed from 
the patient’s blood was puriﬁ  ed and sequenced. A 1,214-
bp sequence was submitted to GenBank (accession no. 
EU888930); it was 99% homologous with the sequence for 
M. haemofelis.
The possibility that the patient’s cats might be involved 
in zoonotic transmission was also investigated. Two weeks 
after the patient’s ﬁ  rst blood collection, blood was collected 
from the 5 cats, and DNA was extracted at the Veterinary 
Hospital of the Universidade Federal do Rio Grande do Sul, 
Porto Alegre. Two of the cats were positive by PCR for M. 
haemofelis and all 5 cats were positive for Bartonella spp. 
The cats were not tested for other infectious agents.
PCRs for hemoplasmas were performed in duplicate 
at 2 laboratories (Universidade de São Paulo, São Paulo, 
Brazil and Purdue University, West Lafayette, IN, USA) by 
using split aliquots. PCR results were reproducible. During 
the patient’s second hospitalization, the same PCRs were 
used and the patient was positive for Bartonella spp. but 
negative for hemoplasmas.
Conclusions
Hemoplasma infections may occur more frequently 
than is generally recognized, given that these organisms 
fail to grow in culture and only a few laboratories are 
equipped to detect and identify hemoplasmas (1). Disease 
associations with latent mycoplasma infections in immu-
nocompromised and nonimmunocompromised patients are 
now emerging. Increasing numbers of human patients with 
compromised immune systems living near cats increases 
the possibility that hemoplasma infections may also emerge 
in this population.
There are no molecular studies to date documenting 
hemoplasma infection in humans. However, it has been 
suggested that such infections may be seen in immunocom-
promised patients (5). A hemotrophic mycoplasma infec-
tion was reported in patients with systemic lupus erythe-
matosus (SLE) (6). A 417-bp sequence detected in 1 SLE 
patient also showed 99% homology with M. haemofelis (7). 
Sequence data from another hemotrophic mycoplasma in-
fection in an anemic human patient were reported in Gen-
Bank. However, the sequence of 178 bp of the 16S rRNA 
gene (accession no. EU014880) was more closely related 
to M. suis and M. wenyonii (96%–100%) and only 75% 
homologous to M. haemofelis (8).
Epidemiologic studies have linked cat bites and scratch-
es and ﬂ  ea-infested cats with transmission of B. henselae 
to humans (9). B. henselae and B. quintana are causative 
agents of bacillary angiomatosis, bacillary peliosis, and 
cat-scratch disease in humans. Peliosis hepatis and lymph 
node angiomatosis, as seen in this patient, have been asso-
ciated with B. henselae infection (10). M. haemofelis DNA 
has also been detected in cat ﬂ  eas (Ctenocephalides felis); 
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Figure. PCR results for detection of a Mycoplasma haemofelis–like 
organism in an HIV-positive patient. Lane 1, 100-bp marker; lane 
2, positive control (DNA from blood of an M. haemofelis–positive 
cat); lane 3, negative control (water); lane 4, DNA from blood of 
the patient.C. felis may be involved in transmission of M. haemofe-
lis among cats (11). Additional studies have documented 
experimental transmission by administration of infected 
blood intravenously, intraperitoneally, and orally. Hemo-
plasma DNA is present in saliva and feces of cats, which 
suggests that aggressive interactions among cats involving 
biting may lead to transmission of the organism (12). To 
our knowledge, there is only 1 other report that cats can be 
co-infected with M. haemofelis and B. henselae (13).
As with other Mycoplasma spp., hemoplasmas might 
act as a cofactor in HIV infection, contributing to accelera-
tion of the course of the disease (14). Further studies are 
needed to establish the role and prevalence of hemoplasma 
infection in AIDS patients, as well as the zoonotic potential 
of M. haemofelis.
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